Abstract
Background As the COVID-19 Omicron variant emerged and spread globally at an alarming speed, healthcare workers’ (HCWs) uncertainties, worries, resilience, and coping strategies warrant assessment. The COVID-19 pandemic had a severe psychological impact on HCWs, including the development of Post-Traumatic Stress symptoms. Specific subgroups of HCWs, such as front-line and female workers, were more prone to poor mental health outcomes and difficulties facing stress.
Methods The responses to an online questionnaire among HCWs in Saudi Arabia (KSA) were collected December 1-5, 2021, aiming to assess their Omicron variant’s uncertainties, worries, resilience, and coping strategies. Three validated instruments were used to achieve the study’s goals: the Brief Resilient Coping Scale, the Standard Stress Scale (SSS), and the Intolerance of Uncertainty Scale (IUS) - Short Form.
Results The online survey was completed by 1285 HCWs. Females made up the majority (64%). The BRCS score of resilient coping was negatively and substantially linked with the SSS score of stress (r=-0.313, p = 0.010). Furthermore, the IUS had a positive and significant relationship with stress (r=0.326, p= 0.010). Increased stress levels were linked to a considerable drop in resilient coping scores. Furthermore, being a Saudi HCW or a nurse was linked to a significant reduction in resilient coping ratings. Coping by following healthcare authorities’ preventative instructions and using the WHO website as a source of information was linked to a considerable rise in resilient coping.
Conclusions Following the emergence of the Omicron variant of SARS-CoV-2 in late 2021, a rapid investigation into the correlates of stress and resilient coping among the HCWs in KSA was conducted. The negative association between resilient coping and stress was clearly shown, as well as how underlying intolerance of uncertainty is linked to higher stress among HCWs quickly following the development of a new infectious threat. The study provides early insights to develop and promote coping strategies for emerging SARS-CoV-2 variants.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethics committee/IRB of King Saud University gave ethical approval for this work (approval 21/01039/IRB).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Author emails: Mohamad-Hani Temsah (MHT): PO BOX 2925, Riyadh 11461, Saudi Arabia mtemsah{at}ksu.edu.sa
Shuliweeh Alenezi: PO BOX 7747, Riyadh, 13321 salenizi{at}ksu.edu.sa
Mohamad Alarabi : PO BOX 2925, Riyadh 11461, Saudi Arabia malarabi{at}ksu.edu.sa
Fadi Aljamaan (FAJ): PO BOX 2925, Riyadh 11461, Saudi Arabia faljamaan{at}ksu.edu.sa
Khalid Alhasan (KAH): PO BOX 2925, Riyadh 11461, Saudi Arabia kalhasan{at}ksu.edu.sa
Rasha Assiri raassiri{at}pnu.edu.sa
Rolan Bassrawi rkbassrawi{at}ksu.edu.sa,
Fatimah Alshahrani : Falshahrani1{at}ksu.edu.sa
Ali Alhaboob (AAH): PO BOX 2925, Riyadh 11461, Saudi Arabia drhbooob{at}gmail.com
Ali Alaraj (AAA): PO BOX 12471, Riyadh, Saudi Arabia al_araj{at}hotmail.com
Naser S Alharbi nsalharbi{at}ksu.edu.sa
Rabih Halwani: rhalwani{at}sharjah.ac.ae
Amr Jamal amrjamal{at}ksu.edu.sa
Naif Abdulmajeed Dr.naifq{at}gmail.com
Lina Alfarra Lalfarra19811{at}gmail.com
Wafa almashdali Almashdali{at}gmail.com
Ayman Al-Eyadhy aleyadhy{at}ksu.edu.sa
Fahad Al-Zamil fzamil{at}KSU.EDU.SA
Sarah Al-Subaie salsubaie{at}ksu.edu.sa
Mazin Barry mbarry{at}ksu.edu.sa
Ziad Memish zmemish{at}yahoo.com
Jaffar A. Al-Tawfiq jaltawfi{at}yahoo.com
Conflict of interest: None declared.
Ethics approval and consent to participate: The study was approved by the institutional review board of King Saud University (approval 21/01039/IRB).
Abbreviations
- BRCS
- Brief Resilient Coping Scale
- CDC
- Centers for Disease Control and Prevention
- COVID-19
- Coronavirus disease 2019
- HCW
- healthcare workers
- IUS
- Intolerance of Uncertainty Scale
- MoH
- Ministry of Health
- SARS-CoV-2
- Severe acute respiratory syndrome coronavirus 2
- SSS
- Standard Stress Scale
- WHO
- World Health Organization
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos